Two former executives of the Bill & Melinda Gates Foundation have a plan to support young biotech companies, and they are armed with $200 million to do it.
Boris Nikolic and Julie Sunderland launched Seattle venture-capital firm Biomatics Capital last year, and originally sought to raise $150 million for its first fund. It ended up closing with $200 million, the company announced Wednesday.
Image: Julie Sunderland, previously director of program-related investments at The Bill & Melinda Gates Foundation, launched Biomatics Capital with Boris Nikolic to invest in young biotech companies. (Courtesy of Biomatics Capital)
